Automated Multiplex CRISPR-Cas12f (CasMINI) Vector Foundry Cap Rate 2026

Underwrite GMP Class A/B continuous synthetic ultra-compact Cas12f (400-500 amino acid CasMINI) all-in-one single-AAV viral vector manufacturing suites, $585/sqft base lease rates, and exit cap rates.

Underwriting Assumptions

CasMINI Cleanroom Footprint (sqft)

NNN Base Lease Rate ($/sqft/yr)

Turnkey GMP CasMINI Foundry Acquisition ($)

Target Exit Capitalization Rate (%)

Projected Economics

Net Operating Income (NOI)

Going-In Capitalization Rate

Stabilized Institutional Valuation